Rise in surgical robots will drive growth for Mazor Robotics

Rise in surgical robots will drive growth for Mazor Robotics

A Member of Pat McKeough’s Inner Circle recently requested his advice on an Israeli company in a rapidly-growing area of medicine.

Mazor Robotics develops systems for computer-assisted surgery, specifically spinal and brain surgeries. The company has produced two robotic systems; it receives 57% of its… Read More

Q: Pat: Thanks for all the great advice over the years. Could you please give me your opinion on Mazor Robotics? Thank you very much.

A: Mazor Robotics (ADR), $47.14, symbol MZOR on Nasdaq (Shares outstanding: 26.4 million; Market cap: $1.4 billion; www.mazorrobotics.com), is an Israeli company that develops and markets computerized and imaging systems for spine and brain surgeries.

Computer-assisted surgery enables the use of surgical instruments with high precision… Read More

Successful medical devices spurs revenue

Medical device companies operate in an expanding market now worth about $500 billion a year. An aging population, increasing health-care spending and technological advances have fuelled 5% growth per year. The industry is expected to maintain that pace for the foreseeable future.
However, developing a new… Read More

Aging population fuels these ETFs

There’s little doubt that the developing world’s aging population will continue to spend more on medical services for years to come. Medical device makers are well positioned to capture a share of that increased spending. In turn, investors in the industry’s leading companies stand to… Read More

Four dividend ETFs—four strategies

Rising interest rates mean dividend-paying stocks and fixed-income instruments must increasingly compete for investor interest. However, sustainable dividends still offer an attractive and growing income stream for investors (see supplement on page 50).
Here are four ETFs that provide exposure to Canadian, U.S. and international dividend… Read More

Profit from an aging population

Declining fertility rates and rising life expectancies are responsible for a rapidly aging global population. In North America and Europe, the average senior retires relatively wealthy and plans to spend a significant portion of their money on staying healthy.

Here we look at two ETFs… Read More

Renaissance Global Health Care Fund (Formerly Talvest Global Health Care Fund)

RENAISSANCE GLOBAL HEALTH CARE FUND $49.93 (Renaissance Investments, 1500 Robert Bourassa Blvd., Suite 800, Montreal, PQ. H3A 3S6. 1-800-268-8258; Web site: www.renaisanceinvestments.ca. Available from brokers) invests primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or whose securities are traded… Read More

Renaissance Global Health Care Fund $15.78

RENAISSANCE GLOBAL HEALTH CARE FUND $44.77 (CWA Rating: Speculative) (Renaissance Investments, 1500 Robert Bourassa Blvd., Suite 800, Montreal, PQ. H3A 3S6. 1-800-268-8258; Web site: www.renaisanceinvestments.ca. Available from brokers) invests primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or… Read More

RENAISSANCE GLOBAL HEALTH CARE FUND $15.19

RENAISSANCE GLOBAL HEALTH CARE FUND $44.77 (CWA Rating: Speculative) (Renaissance Investments, 1500 Robert Bourassa Blvd., Suite 800, Montreal, PQ. H3A 3S6. 1-800-268-8258; Web site: www.renaisanceinvestments.ca. Available from brokers) invests primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or… Read More